Forget gold and Bitcoin. I’d buy this FTSE 100 dividend bargain in an ISA as stock markets crash

Wake up ISA investors! This bargain dividend income stock could be the best buy on the FTSE 100 (INDEXFTSE:UKX) as stock markets crash.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

The world’s greatest investor Warren Buffett knows exactly what to do in a stock market crash like this one. “Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.”

The FTSE 100 is full of quality companies that have been marked down as share prices crash, and my favourite is pharmaceutical giant GlaxoSmithKline (LSE: GSK). I would much rather buy the falling Glaxo share price inside a Stocks and Shares ISA, than gold or crypto-currency Bitcoin.

The gold price has disappointed. It usually rises when share prices fall, because investors see it as a safe haven. Not this time. Instead of buying gold, many far-sighted investors have been selling it to invest in today’s crashing share prices. That would be my strategy.

Forget gold, forget Bitcoin

Bitcoin has also disappointed investors who thought it was a safe bolthole. Before Covid-19, Bitcoin traded at more than $10,000, but has slumped to around $6,000. That’s a crash of 40%, greater than the 25% drop on the FTSE 100.

Personally, I would ignore gold and Bitcoin in favour of buying top FTSE 100 stocks like Glaxo, tax free in a Stocks and Shares ISA. The Glaxo share price has fallen 20% from its mid-January high, to 1,475p, at time of writing. That’s a relatively small drop, by the standards of today’s stock market crash.

I’d buy Glaxo in an ISA

Glaxo is what is known as a defensive stock. As a FTSE 100 healthcare giant, it should have relatively steady income. People still fall ill in a recession and need pharmaceutical medicines, vaccines, and consumer healthcare products, which is what Glaxo produces.

Pharmaceutical stocks look even more tempting now, given that today’s stock market crash has been triggered by a health crisis. As a leading vaccine maker, Glaxo is collaborating with a range of companies and institutions to help find, make, and produce a vaccine. 

There’ll be no political mileage in cutting health budgets after everything Western countries have been through. Glaxo is a stock for this crisis and beyond. 

A top buy for this stock market crash

Glaxo has been focusing on boosting its pipeline of drugs and treatments, which will drive future revenues. To fund this, management has frozen the dividend at 80p since 2016. However, Glaxo still yields an attractive 5.5% a year, covered 1.4 times by earnings. That’s tax free inside a Stocks and Shares ISA.

Even if Glaxo cut or scrapped its dividend in response to the crisis, the payout will be back.

The other big attraction of the Glaxo share price is that the FTSE 100 stock market crash has left it trading at just 12 times earnings, the cheapest valuation I can recall. Typically, investors pay between 16 and 18 times, and often more.

Glaxo is what Buffett would call quality merchandise, marked down. Right now, it looks a top buy for investors willing to hold for the long term.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »